Daratumumab (anti-CD38) is a recombinant monoclonal antibody against CD38. Daratumumab is an investigational cancer drug indicated for the treatment of adult patients with multiple myeloma.
Anti-mCD25 antibody
Anti mCD25 mouse monoclonal antibody
Anti-mCCR8 mouse mAb
Anti mCCR8 mouse monoclonal antibody
OPDIVO (nivolumab)
OPDIVO (nivolumab) is a treatment for previously treated patients with advanced squamous non-small cell lung cancer (NSCLC).